Estrogen receptor ligands

US9586891B2 · kind B2 · utility

Assignee

• Karo Pharma AB · SE

Inventors

• Aiping Cheng · Huddinge, SE
• Neeraj Garg · Tumba, SE
• Lars Krüger · Huddinge, SE
• Joakim Löfstedt · Uppsala, SE
• Eva Koch · Huddinge, SE
• Konrad Koehler · Huddinge, SE
• Lars Hagberg · Huddinge, SE
• Daniel Nöteberg · Huddinge, SE

Key dates

• Filing date: Aug 2, 2012
• Grant date: Mar 7, 2017
• Expiry date: Nov 23, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estrogen receptor ligands.